These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36676791)

  • 1. Matrix Metalloproteinase-9 Level in Synovial Fluid-Association with Joint Destruction in Early Rheumatoid Arthritis.
    Stojanovic SK; Stamenkovic BN; Cvetkovic JM; Zivkovic VG; Apostolovic MRA
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tumor necrosis factor-α (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
    Stojanovic S; Bojana Stamenkovic ; Stoimenov TJ; Nedovic J; Zivkovic V; Despotovic M; Pavlovic D
    Clin Rheumatol; 2017 Jul; 36(7):1479-1485. PubMed ID: 28573370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
    Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
    Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides.
    Kageyama Y; Miyamoto S; Ozeki T; Hiyohsi M; Suzuki M; Nagano A
    Clin Rheumatol; 2000; 19(1):14-20. PubMed ID: 10752493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
    Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
    Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial IL-21/TNF-producing CD4
    Lebre MC; Vieira PL; Tang MW; Aarrass S; Helder B; Newsom-Davis T; Tak PP; Screaton GR
    J Leukoc Biol; 2017 Mar; 101(3):775-783. PubMed ID: 27733582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
    Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
    BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis.
    Kim KS; Choi HM; Lee YA; Choi IA; Lee SH; Hong SJ; Yang HI; Yoo MC
    Rheumatol Int; 2011 Apr; 31(4):543-7. PubMed ID: 20665024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
    J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases.
    Agarwal S; Misra R; Aggarwal A
    J Rheumatol; 2008 Mar; 35(3):515-9. PubMed ID: 18203309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
    Fraser A; Fearon U; Reece R; Emery P; Veale DJ
    Arthritis Rheum; 2001 Sep; 44(9):2024-8. PubMed ID: 11592363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor activator of nuclear factor kappa B ligand serum and synovial fluid level. A comparative study between rheumatoid arthritis and osteoarthritis.
    Ellabban AS; Kamel SR; Ahmed SS; Osman AM
    Rheumatol Int; 2012 Jun; 32(6):1589-96. PubMed ID: 21328055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3.
    Koskinen A; Vuolteenaho K; Moilanen T; Moilanen E
    Scand J Rheumatol; 2014; 43(3):249-53. PubMed ID: 24780007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand.
    Matsuno H; Yudoh K; Watanabe Y; Nakazawa F; Aono H; Kimura T
    J Rheumatol; 2001 Jan; 28(1):22-8. PubMed ID: 11196534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
    Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
    Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.